Results 41 to 50 of about 34,873 (303)
PLoS ONE, 2020 BackgroundGiving patients anti-osteoporotic agents peri-operatively is a well-accepted strategy to increase fusion rate and prevent complications. The purpose of this study was to investigate effectiveness of teriparatide and bisphosphonate on fusion ...
Shih-Hao Cheng +3 more
doaj +1 more source
eLife, 2022 Bisphosphonate-related osteonecrosis of the jaw (BRONJ) presents as a morbid jawbone lesion in patients exposed to a nitrogen-containing bisphosphonate (N-BP). Although it is rare, BRONJ has caused apprehension among patients and healthcare providers and
Hiroko Okawa +13 more
doaj +1 more source
Trauma Case Reports, 2020 Osteoporotic patients being treated with bisphosphonates present an interesting dilemma when removing hardware such as dynamic hip screws “DHS”. In this paper, we describe the case of a 66-year-old osteoporotic patient who was placed on long term ...
Bardia Barimani +4 more
doaj +1 more source
Etidronate as A Weak Chelating Agent on Root Canal Dentin: An Update Review [PDF]
Journal of Clinical and Diagnostic Research, 2017 Successful root canal treatment depends on proper biomechanical cleaning and shaping of root canal system followed by threedimensional obturation. Irrigation solutions and chelating agents are used during root canal treatment to assist in smear layer ...
Samah Samir Bedir +2 more
doaj +1 more source
Advanced Materials, EarlyView.Oxygen‐releasing hydrogels are widely used to support cell survival in 3D cultures and to promote wound healing. However, incorporating catalase to convert H2O2 into O2 often generates additional oxygen bubbles, leading to material instability which rarely addressed.
Sukulya Bunuasunthon +3 more
wiley +1 more source
Hypomagnesemia and vitamin D deficiency complicating bisphosphonate induced hypocalcaemia [PDF]
, 2012 Zolendronic acid is a potent bisphosphonate that is used to treat patients with metastatic cancer by reducing bone pain and preventing skeletal complications of bone metastasis.
Bigeni, Josephine, Vella, Antoine
core
Atypical femoral fracture: The periprosthetic variant about two cases without bisphosphonate use
SICOT-JAtypical femoral fractures are rare. They are well described in patients with prolonged bisphosphonate use. The periprosthetic form without bisphosphonate intake appears to be exceptional and may lead to mechanical complications (nonunion, secondary ...
Auberger Guillaume +4 more
doaj +1 more source
Mechanical Activation of Piezo1 Drives Osteoarthritis Through Kdm5c‐Mediated Epigenetic Silencing
Advanced Science, EarlyView.Excessive mechanical stress activates Piezo1, triggering Ca2+‐dependent cytoskeletal forces that deform the nucleus and reduce H3K4me3. Kdm5c demethylates H3K4me3 at Col2a1 and Runx3 promoters. Kdm5c knockout rescues degradation. Repurposed telmisartan directly inhibits Kdm5c, blocking this axis and showing disease‐modifying efficacy in mouse OA models
Tianyou Kan +13 more
wiley +1 more source
Bisphosphonate und atypische Femurfrakturen [PDF]
, 2011 Bei der Anwendung von Bisphosphonaten besteht ein Risiko für das Auftreten atypischer Femurfrakturen. Dies ist das Ergebnis eines kürzlich durchgeführten Bewertungsverfahrens des Ausschusses für Humanarzneimittel (CHMP) der Europäischen ...
Diesinger, Christine
core +1 more source
Anti‐Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture
Orthopaedic Surgery, 2019 Objective To study the effect of anti‐osteoporosis therapies on mortality after hip fracture. Methods This retrospective study was carried out in the Second Affiliated Hospital of Fujian Medical University and enrolled 690 patients 50 years of age and ...
Pei‐wen Wang +8 more
doaj +1 more source